<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:hpo ids='HP_0002045'>Hypothermia</z:hpo> is effective in improving outcome in experimental models of <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We studied the feasibility and safety of <z:hpo ids='HP_0002045'>hypothermia</z:hpo> in patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> treated with thrombolysis </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: An open study design was used </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients presented with major <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> (National Institutes of Health <z:hpo ids='HP_0001297'>Stroke</z:hpo> Scale [NIHSS] score &gt;15) within 6 hours of <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>After informed consent, patients with a persistent NIHSS score of &gt;8 were treated with <z:hpo ids='HP_0002045'>hypothermia</z:hpo> to 32+/-1 degrees C for 12 to 72 hours depending on vessel patency </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were monitored in the neurocritical care unit for complications </plain></SENT>
<SENT sid="6" pm="."><plain>A modified Rankin Scale was measured at 90 days and compared with concurrent controls </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Ten patients with a mean age of 71.1+/-14.3 years and an NIHSS score of 19.8+/-3.3 were treated with <z:hpo ids='HP_0002045'>hypothermia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Nine patients served as concurrent controls </plain></SENT>
<SENT sid="9" pm="."><plain>The mean time from symptom <z:hpo ids='HP_0003674'>onset</z:hpo> to thrombolysis was 3.1+/-1.4 hours and from symptom <z:hpo ids='HP_0003674'>onset</z:hpo> to initiation of <z:hpo ids='HP_0002045'>hypothermia</z:hpo> was 6.2+/-1.3 hours </plain></SENT>
<SENT sid="10" pm="."><plain>The mean duration of <z:hpo ids='HP_0002045'>hypothermia</z:hpo> was 47.4+/-20.4 hours </plain></SENT>
<SENT sid="11" pm="."><plain>Target temperature was achieved in 3.5+/-1.5 hours </plain></SENT>
<SENT sid="12" pm="."><plain>Noncritical complications in <z:hpo ids='HP_0002045'>hypothermia</z:hpo> patients included <z:hpo ids='HP_0001662'>bradycardia</z:hpo> (n=5), ventricular ectopy (n=3), <z:hpo ids='HP_0002615'>hypotension</z:hpo> (n=3), <z:hpo ids='HP_0002249'>melena</z:hpo> (n=2), <z:hpo ids='HP_0001945'>fever</z:hpo> after rewarming (n=3), and <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> (n=4) </plain></SENT>
<SENT sid="13" pm="."><plain>Four patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> developed rapid ventricular rate, which was noncritical in 2 and critical in 2 patients </plain></SENT>
<SENT sid="14" pm="."><plain>Three patients had <z:hpo ids='HP_0001658'>myocardial infarctions</z:hpo> without sequelae </plain></SENT>
<SENT sid="15" pm="."><plain>There were 3 <z:hpo ids='HP_0011420'>deaths</z:hpo> in patients undergoing <z:hpo ids='HP_0002045'>hypothermia</z:hpo> </plain></SENT>
<SENT sid="16" pm="."><plain>The mean modified Rankin Scale score at 3 months in <z:hpo ids='HP_0002045'>hypothermia</z:hpo> patients was 3.1+/-2.3 </plain></SENT>
<SENT sid="17" pm="."><plain>CONCLUSION: Induced <z:hpo ids='HP_0002045'>hypothermia</z:hpo> appears feasible and safe in patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> even after thrombolysis </plain></SENT>
<SENT sid="18" pm="."><plain>Refinements of the cooling process, optimal target temperature, duration of therapy, and, most important, clinical efficacy, require further study </plain></SENT>
</text></document>